• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Jim Stommen

Jim Stommen

Articles

ARTICLES

The MDD Interview: Company makes advances in areas of large unmet medical needs

May 10, 2012
By Jim Stommen
Robert Hubert is president and CEO of EKOS (Bothell, Washington), bringing to EKOS more than 20 years of marketing, sales, and general management experience in a broad range of medical device companies, from start-up to Fortune 10.
Read More

The MDD Interview: Plan of attack focuses on the disabling factors affecting recycling

May 3, 2012
By Jim Stommen
Tod Christenson wears many hats. He is a partner in the Global Corporate Consultancy of Antea Group, an international environmental engineering and sustainability consulting firm, serving as leader of the group's Value Chain Optimization Practice. He has served since 2006 as director of the Beverage Industry Environmental Roundtable, a coalition of 17 global beverage companies working to advance environmental sustainability across the beverage sector. In his newest role, he also serves as director of the Healthcare Plastics Recycling Council (HPRC), a consortium of twelve global medical products manufacturers, waste management service companies, resin manufacturers, and plastic recyclers whose mission it is "to inspire and enable plastics recycling solutions in the delivery of healthcare."
Read More

The MDD Interview: Medical recycling effort seeks answers to complex questions

April 26, 2012
By Jim Stommen
Tod Christenson wears many hats. He is a partner in the Global Corporate Consultancy of Antea Group, an international environmental engineering and sustainability consulting firm, serving as leader of the group's Value Chain Optimization Practice.
Read More

What’s up, doc? Survey says ‘lying weasel’ doesn’t only apply to miscreant football coaches

April 24, 2012
By Jim Stommen
The recent hubbub about ex-University of Arkansas football coach Bobby Petrino, which centered on the latest examples of his propensity for lying to his superiors, got me to thinking. Not so much about how proven prevaricator Petrino finally lied his way into the ranks of the unemployed, although I did enjoy reading statements such as this classic from SI.com writer Michael Rosenberg: “The . . . university is shocked to discover that its lying-weasel football coach is a lying weasel.” Rather, the extensive coverage of the circumstances of Petrino’s self-inflicted fall from grace led me to revisit a question that...
Read More

The MDD Interview: Shimer: Part of outcomes is patient satisfaction, and we're on it

April 19, 2012
By Jim Stommen
Julie Shimer, president and CEO of Welch Allyn (Skaneateles Falls, New York), hands over reins of the company to new President/CEO Stephen Meyer this month after announcing plans in January to retire this year. Shimer was the first female CEO of the company, a maker of medical diagnostic and monitoring equipment and software solutions, assumed that role in 2007 after serving as a member of the firm's board of directors beginning in 2002.
Read More

The MDD Interview: Founding family's values added to appeal of CEO post for Shimer

April 12, 2012
By Jim Stommen
Julie Shimer, president/CEO of Welch Allyn (Skaneateles Falls, New York), will hand over reins of the company to new President/CEO Stephen Meyer this month after announcing plans in January to retire this year. Shimer was the first female CEO of the company, a maker of medical diagnostic and monitoring equipment and software solutions, assuming that role in 2007 after serving as a member of the firm's board of directors beginning in 2002.
Read More

The MDD Interview: Belson: 'You never know where you'll finish,' so be flexible

April 5, 2012
By Jim Stommen
Amir Belson, MD, is a serial entrepreneur who has thus far founded nine companies, including NeoGuide Systems (Los Gatos, California), a company that developed platform technology for minimally invasive surgical procedures and was acquired by Intuitive Surgical (Sunnyvale, California) in 2009. His latest start-up firm is Zipline Medical (also Los Gatos), which is developing a technology platform designed to facilitate noninvasive surgical skin closure with suture-like outcomes at the speed of staples.
Read More

The MDD Interview: Ideas abound, but entrepreneur follows a set of rules

March 29, 2012
By Jim Stommen
Amir Belson, MD, is a serial entrepreneur who has thus far founded nine companies, including NeoGuide Systems (Los Gatos, California), a company that developed platform technology for minimally invasive surgical procedures and was acquired by Intuitive Surgical (Sunnyvale, California) in 2009. His latest start-up firm is Zipline Medical also Los Gatos), a wound closure company.
Read More

Unhappiness of physicians is reflected in some startling numbers in career-recommendation survey

March 19, 2012
By Jim Stommen
As I read through one particular healthcare-related news item recently, the lyrics to the old “If you’re happy and you know it” song just plain took over my subconscious thinking. You know the one I’m talking about: “If you’re happy and you know it, then your face will surely show it.” It may not come as any great surprise that smiles aren’t adorning the faces of too many doctors these days, what with Medicare payment cuts, the looming impact of healthcare reform, skyrocketing malpractice premiums and other lesser complaints and concerns. But all that notwithstanding, it was just short of...
Read More

The MDD Interview: Eric Topol to patients: It's your data, take charge of it!

March 14, 2012
By Jim Stommen
Eric Topol, MD, is a pioneer of the use of genomic and wireless digital innovative technologies to reshape the future of medicine. Widely known for his genetic research, he is a practicing cardiologist at Scripps Clinic (La Jolla, California), and director of the Scripps Translational Science Institute after previously chairing the Cleveland Clinic's top-ranked department of cardiovascular medicine. In his newly published book, "The Creative Destruction of Medicine," Topol advocates that patients, as healthcare consumers, rise up to demand control of their care through a digital-based true partnership with physicians.
Read More
View All Articles by Jim Stommen

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 13, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 13, 2025.
  • Koreabio Humanase KOH Sungho

    FDA shift from animal testing fuels organoid, organ-on-chip demand

    BioWorld Science
    The U.S. FDA’s decision to phase out animal testing for INDs is driving a new market of alternative, nonanimal testing technologies like organoids and...
  • AI generated, 3D rendering of protein degradation

    AACR 2025: Induced proximity strategy, beyond degraders

    BioWorld
    Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
  • Neuroplastin 65 knockout disrupts visual function by altering the retina

    BioWorld Science
    Researchers from Tongji University School of Medicine and collaborating institutions have discovered that NP65 plays a crucial role in maintaining normal visual...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe